Literature DB >> 16026286

Endothelial activation. Sliding door to atherosclerosis.

Giovambattista Desideri1, Claudio Ferri.   

Abstract

The vascular endothelium has been long viewed as a simply physical separation between blood and tissue [1]. Over the last two decades a consistent bulk of data demonstrated that endothelium is a widely distributed organ, with a variable degree of heterogeneity among and within tissues [2, 3] and deeply involved in vascular physiology and pathophysiology, rather than a cellophane-like membrane that lines the circulatory system [1]. Being positioned at the interface of blood and tissue, the vascular endothelium is able to sense changes in hemodynamic forces and biochemical stimuli and promptly responds to local changes in biological needs by modulating vasomotion, hemostasis, angiogenesis, and vascular growth [1]. The vascular endothelium also modulates the trafficking of circulating blood cells by up-regulating adhesion molecules on cell surface [1, 4, 5]. These cell membrane-associated molecules are critic for leukocyte migration into specific organs under physiologic conditions and accelerate migration towards sites of inflammation [1, 4, 5]. Recently, the multi-step cascade of events that results in the local recruitment of leukocytes to sites of inflammatory challenge, also known as endothelial activation, has been considered as a crucial step in the initiation of atherosclerosis process, as well as in the development of advanced atherosclerosis [6].

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16026286     DOI: 10.2174/1381612054367382

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  18 in total

1.  Extensive deendothelialization and thrombogenicity in routinely prepared vein grafts for coronary bypass operations: facts and remedy.

Authors:  Dominik R Weiss; Gerd Juchem; Bernhard M Kemkes; Brigitte Gansera; Stephan Nees
Journal:  Int J Clin Exp Med       Date:  2009-05-28

2.  Inflammasome Signaling and Impaired Vascular Health in Psoriasis.

Authors:  Michael S Garshick; Tessa J Barrett; Todd Wechter; Sarah Azarchi; Jose U Scher; Andrea Neimann; Stuart Katz; Judilyn Fuentes-Duculan; Maria V Cannizzaro; Sanja Jelic; Edward A Fisher; James G Krueger; Jeffrey S Berger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

3.  Genipin Selectively Inhibits TNF-α-activated VCAM-1 But Not ICAM-1 Expression by Upregulation of PPAR-γ in Human Endothelial Cells.

Authors:  Jung Seok Hwa; Lidiya Mun; Hye Jung Kim; Han Geuk Seo; Jae Heun Lee; Jong Hwan Kwak; Dong-Ung Lee; Ki Churl Chang
Journal:  Korean J Physiol Pharmacol       Date:  2011-06-30       Impact factor: 2.016

4.  Nanoparticle Functionalization with Platelet Membrane Enables Multifactored Biological Targeting and Detection of Atherosclerosis.

Authors:  Xiaoli Wei; Man Ying; Diana Dehaini; Yuanyuan Su; Ashley V Kroll; Jiarong Zhou; Weiwei Gao; Ronnie H Fang; Shu Chien; Liangfang Zhang
Journal:  ACS Nano       Date:  2017-12-12       Impact factor: 15.881

5.  ORAL ADMINISTRATION OF PCBs INDUCES PROINFLAMMATORY AND PROMETASTATIC RESPONSES.

Authors:  Sandor Sipka; Sung-Yong Eum; Kwang Won Son; Shifen Xu; Vasileios G Gavalas; Bernhard Hennig; Michal Toborek
Journal:  Environ Toxicol Pharmacol       Date:  2008-03       Impact factor: 4.860

6.  Effect of Interleukin-10 and Laminar Shear Stress on Endothelial Nitric Oxide Synthase and Nitric Oxide in African American Human Umbilical Vein Endothelial Cells.

Authors:  Dianne M Babbitt; Ji-Seok Kim; Steven J Forrester; Michael D Brown; Joon-Young Park
Journal:  Ethn Dis       Date:  2015-11-05       Impact factor: 1.847

7.  CCL20 in psoriasis: A potential biomarker of disease severity, inflammation, and impaired vascular health.

Authors:  Youssef A Elnabawi; Michael S Garshick; Michael Tawil; Tessa J Barrett; Edward A Fisher; Kristen Lo Sicco; Andrea L Neimann; Jose U Scher; James Krueger; Jeffrey S Berger
Journal:  J Am Acad Dermatol       Date:  2020-11-28       Impact factor: 11.527

Review 8.  Flavonoids: antioxidants against atherosclerosis.

Authors:  Davide Grassi; Giovambattista Desideri; Claudio Ferri
Journal:  Nutrients       Date:  2010-08-12       Impact factor: 5.717

Review 9.  Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases.

Authors:  Theodoros Dimitroulas; Aamer Sandoo; George D Kitas
Journal:  Int J Mol Sci       Date:  2012-09-26       Impact factor: 5.923

10.  Pharmacokinetics and modeling of immune cell trafficking: quantifying differential influences of target tissues versus lymphocytes in SJL and lipopolysaccharide-treated mice.

Authors:  William A Banks; Michael L Niehoff; Nicholas M Ponzio; Michelle A Erickson; Steven S Zalcman
Journal:  J Neuroinflammation       Date:  2012-10-03       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.